SRC
ISEE

Shufro Rose & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Shufro Rose & Co’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,975
Closed -$506K – 268
2016
Q3 		$506K Sell
10,975
-1,000
-8% -$56.4K 0.06% 155
2016
Q2 		$611K Sell
11,975
-1,500
-11% -$74.5K 0.07% 146
2016
Q1 		$570K Buy
13,475
+1,900
+16% +$96.8K 0.06% 151
2015
Q4 		$908K Sell
11,575
-300
-3% -$17.3K 0.1% 122
2015
Q3 		$481K Buy
+11,875
New +$629K 0.06% 156

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shufro Rose & Co's ISEE Position: Q4 2016 in Review

Shufro Rose & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 10,975 shares — an estimated $506K sold.

Shufro Rose & Co first reported a position in ISEE in Q3 2015 and held it in 5 quarters. The position peaked at $908K in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Shufro Rose & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Shufro Rose & Co sold 10,975 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $506K.
  • Shufro Rose & Co first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
  • Shufro Rose & Co's IVERIC bio, Inc. Common Stock position peaked at $908K in Q4 2015.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Shufro Rose & Co's 13F filing for Q4 2016, filed 8 Feb 2017.